These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9173200)

  • 1. [APC resistance, oral contraceptives and thrombosis. Screening is justified for diagnosing high-risk cases].
    Dahlbäck B
    Lakartidningen; 1997 Apr; 94(16):1522-4. PubMed ID: 9173200
    [No Abstract]   [Full Text] [Related]  

  • 2. [P pills and APC resistance. General screening is not justified].
    Milsom I; Odlind V
    Lakartidningen; 1997 Mar; 94(13):1208-9. PubMed ID: 9148063
    [No Abstract]   [Full Text] [Related]  

  • 3. [A test for APC resistance prior to prescription of oral contraceptives? Discussion about screening should be based on facts].
    Dahlbäck B
    Lakartidningen; 1995 Nov; 92(48):4558, 4561. PubMed ID: 7490973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Public health economic evaluation of screening for APC resistance (Leiden mutation) in new oral contraceptive users].
    Szucs T; Osterkorn D; Schramm W
    Med Klin (Munich); 1996 May; 91(5):317-9. PubMed ID: 8709911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tests which can prevent thrombosis. "They are too expensive", say physicians].
    Ajanki T
    Vardfacket; 1997 Oct; 21(9):28-9. PubMed ID: 9393138
    [No Abstract]   [Full Text] [Related]  

  • 9. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?
    Mac Gillavry MR; Prins MH
    Semin Thromb Hemost; 2003 Apr; 29(2):219-26. PubMed ID: 12709926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [APC (activated protein C) resistance and oral contraceptives].
    Kreis I; Weiss T; Rabe TN; Ziegler R; Nawroth PP
    Geburtshilfe Frauenheilkd; 1996 May; 56(5):231-3. PubMed ID: 8768059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of thrombosis with oral contraceptives--si tacuisses].
    Huber JC
    Zentralbl Gynakol; 1996; 118(12):697-9. PubMed ID: 9082710
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal treatment in women and thrombosis].
    Kaaja R; Heikinheimo O; Rasi V
    Duodecim; 1999; 115(11):1235-43. PubMed ID: 11877844
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives, hormone replacement therapy and thrombosis.
    Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Thromb Haemost; 2001 Jul; 86(1):112-23. PubMed ID: 11486996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraceptives and thrombosis].
    Lidegaard Ø; Schiødt AV; Poulsen EF
    Ugeskr Laeger; 2001 Aug; 163(34):4549-53. PubMed ID: 11530557
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombosis caused by oracl contraceptives. Underreporting to the adverse effects registry].
    Samuelsson E; Hägg S; Bäckström M; Granberg K; Mjörndal T
    Lakartidningen; 1996 Sep; 93(37):3117-8, 3121-4. PubMed ID: 8847932
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
    Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
    Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
    Girolami A; Simioni P; Tormene D
    Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.